- This topic has 2 replies, 2 voices, and was last updated 2 years, 11 months ago by .
- You must be logged in to reply to this topic.
IPF patients taking antifibrotic therapies Ofev or Esbriet had a 37% lower mortality risk than those not treated, a registry-based study says. Read more here.
What do you think of these findings?
Die we will. It will just take longer!
Piet.
Piet, no one gets out of this alive; we all get our ticket. Some are just to better places as a destination. So….I work to just live life now to the best I can for myself. I’m never bored and as things get worse, as they assuredly will, I will find more and different things that fill my mind and soul. Just sayin’.
Rand O’Brien
Pulmonary Fibrosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363
This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.